Published in Cancer Weekly, December 17th, 2002
This marks the second U.S. patent for Virulizin, with the first being issued in 2000 to protect the only known production process of the drug. This recent patent allowance protects the Virulizin invention as it relates to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.